Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Datasets
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study
the European High Resolution Working Group on breast cancer,
Alexander Katalinic
Institute of Social Medicine and Epidemiology
Center for Population Medicine (ZBV)
IRCCS Fondazione Don Carlo Gnocchi - Milano
Portuguese Institute of Oncology Francisco Gentil (IPO Coimbra)
Azienda Unità Sanitaria Locale – IRCCS di Reggio Emilia
Navarra Public Health Institute
Tallinn University of Technology
Biodonostia Health Research Institute
Catalan Institute of Oncology (ICO)
Nantes University Hospital
University of Geneva
Institute of Oncology Ljubljana
London School of Hygiene and Tropical Medicine
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Estrogen Receptor Positive Breast Cancer
100%
Hormone Therapy
100%
Hazard Ratio
63%
Comorbidity
54%
Breast Cancer
27%
Odds Ratio
18%
Logistic Regression Analysis
9%
Cumulative Incidence
9%
Adjuvant Endocrine Therapy
9%
Cause of Death
9%
Pharmacology, Toxicology and Pharmaceutical Science
Endocrine Therapy
100%
Estrogen Receptor Positive Breast Cancer
100%
Comorbidity
54%
Breast Cancer
27%
Cause of Death
9%
Mathematics
Confidence Interval
100%
Hazard Ratio
100%
Cancer Patient
28%
Logistic Regression
14%
Immunology and Microbiology
Comorbidity
100%